Coronavirus vaccine | Pfizer could get U.K. approval this week, says Telegraph


The US Food and Drug Administration announced Friday that it will meet on December 10 to discuss whether to authorize the vaccine.

Britain could give regulatory approval to Pfizer-BioNTech’s COVID-19 vaccine this week, even before the United States allows it, the Telegraph news site reported on Sunday.

Citing government sources, he said UK regulators were about to begin a formal evaluation of the vaccine, carried out by Pfizer Inc and BioNTech SE, and that the National Health Service had been advised to be ready to administer it d ‘by December 1.

Also read: Coronavirus | Pfizer Ends COVID-19 Vaccine Trial With 95% Efficiency, To Request Emergency Use Clearance

the The US Food and Drug Administration said on Friday it will meet on December 10 to discuss the advisability of authorizing the vaccine.

The UK Department of Health made no comment on Sunday on when the first vaccinations would be given.

Also read: Pfizer seeks emergency use of its COVID-19 vaccine in the United States

A spokesperson said that the authorization process by the Medicines and Health Products Medical Regulatory Agency (MHRA) is independent from the government and will take as long as necessary. review final Pfizer data.

“A tremendous amount of planning has taken place to ensure that our health department is ready to deploy a COVID-19 vaccine,” the spokesperson added.

Also read: Coronavirus | Israel signs deal with Pfizer for potential COVID-19 vaccine

Britain officially asked its medical regulator, the MHRA, last week to assess the suitability of the Pfizer-BioNTech vaccine.

Britain has ordered 40 million doses and expects to have 10 million doses, enough to protect 5 million people, available by the end of the year if regulators approve.


Disclaimer: The content and images used in this article is rewritten by the authors of NewsTube and sourced from for more information read our Privacy Policy.


Please enter your comment!
Please enter your name here